Ac4ManNAz

CAS No. 361154-30-5

Ac4ManNAz ( —— )

Catalog No. M21882 CAS No. 361154-30-5

Ac4ManNAz is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 45 In Stock
10MG 72 In Stock
25MG 160 In Stock
50MG 241 In Stock
100MG 357 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ac4ManNAz
  • Note
    Research use only, not for human use.
  • Brief Description
    Ac4ManNAz is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    Ac4ManNAz is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PROTACs
  • Target
    PROTAC
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    361154-30-5
  • Formula Weight
    430.37
  • Molecular Formula
    C??H??N?O??
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 100 mg/mL (232.36 mM; Need ultrasonic)
  • SMILES
    O=C(N[C@@H]1C(OC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)CN=[N+]=[N-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
  • GSK983

    GSK983 (GSK-983) is a potent, cell penetrant PCAF/GCN5 PROTAC, induces concentration-dependent degradation of PCAF and GCN5 in THP1 cells with DC50 value of 1.5 nM and 3 nM, respectively.

  • Rpn13 degrader WL40

    Rpn13 degrader WL40 (WL40) is a novel covalent ubiquitin receptor Rpn13 degrader by linking the Rpn13 covalent inhibitor RA190 with the cereblon (CRBN) binding ligand thalidomide.

  • BCL6 PROTAC 15

    BCL6 PROTAC 15 is a novel B-cell lymphoma 6 (BCL6) PROTAC, significantly degrade BCL6 in a number of DLBCL cell lines.